Avadel Pharmaceuticals plc 2025 Annual Meeting Results

On July 29, 2025, Avadel Pharmaceuticals plc held its 2025 Annual Meeting of Shareholders. The meeting saw the election of seven directors: Gregory J. Divis, Dr. Eric J. Ende, Geoffrey M. Glass, Dr. Mark A. McCamish, Linda S. Palczuk, Peter J. Thornton, and Dr. Naseem S. Amin, each to serve a one-year term. The shareholders also ratified, on a non-binding advisory basis, the appointment of Deloitte & Touche LLP as the company's independent registered public auditor and accounting firm for the fiscal year ending December 31, 2025. Additionally, the shareholders authorized, in a binding vote, the Audit Committee of the Board to set the auditor's remuneration. No other matters were submitted to or voted on by the shareholders at the meeting.